Potential Utility of Peripherally Applied Loperamide in Oral Chronic Graft-versus-host Disease Related Pain
Open Access
- 19 October 2008
- journal article
- case report
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 38 (12) , 857-860
Abstract
Four patients with oral chronic graft-versus-host disease pain were treated with loperamide oral-rinse solution. Two-week continued use of the drug solution improved not only the pain scores but also the pain-causing disabilities associated with eating, drinking and sleeping, with no noticeable side effects. Current results suggest that the mu-opioid agonist, loperamide, has a potential analgesic effect that could be clinically used as a peripheral analgesic agent for stomatits pain. However, these observations will need to be further confirmed in a randomized-controlled trial.Keywords
This publication has 5 references indexed in Scilit:
- Analgesic effects of loperamide in bone cancer pain in micePharmacology Biochemistry and Behavior, 2005
- Potential utility of the peripheral analgesic properties of morphine in stomatitis-related pain: a pilot studyPain, 2003
- Characterization of the Antihyperalgesic Action of a Novel Peripheral Mu-opioid Receptor Agonist-LoperamideAnesthesiology, 1999
- Basic Studies for the Practical Use of Bitterness Inhibitors: Selective Inhibition of Bitterness by PhospholipidsPharmaceutical Research, 1997
- Graft-vs.-Host DiseaseCritical Reviews in Oral Biology & Medicine, 1997